Orazio Schillaci

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 20

Top Venues

Expert review of medical devices

Expert review of molecular diagnostics

Expert review of anticancer therapy

Expert review of gastroenterology & hepatology

Universita degli Studi di Roma Tor Vergata

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Universita degli Studi di Roma Tor Vergata

Italy

Professore Ordianrio :: Biomedicina e Prevenzione

Publications

Scimeca Manuel, Rita Bonfiglio, Erika Menichini, Loredana Albonici, Nicoletta Urbano, Maria Teresa De Caro, Alessandro Mauriello, Orazio Schillaci, Alessandra Gambacurta, Elena Bonanno
Correction: Scimeca et al. Microcalcifications Drive Breast Cancer Occurrence and Development by Macrophage-Mediated Epithelial to Mesenchymal Transition. Int. J. Mol. Sci. 2019 , 20 , 5633. International journal of molecular sciences 25 (15) (2024)
Scimeca Manuel, Rita Bonfiglio, Erika Menichini, Loredana Albonici, Nicoletta Urbano, Maria Teresa De Caro, Alessandro Mauriello, Orazio Schillaci, Alessandra Gambacurta, Elena Bonanno
Correction: Scimeca et al. Microcalcifications Drive Breast Cancer Occurrence and Development by Macrophage-Mediated Epithelial to Mesenchymal Transition. Int. J. Mol. Sci. 2019 , 20 , 5633. International journal of molecular sciences 25 (15) (2024)
Luca Filippi, Luca Urso, Francesco Bianconi, Barbara Palumbo, Maria Cristina Marzola, Laura Evangelista, Orazio Schillaci
Radiomics and theranostics with molecular and metabolic probes in prostate cancer: towards a personalised approach. Expert review of molecular diagnostics (2023)
Luca Filippi, Luca Urso, Francesco Bianconi, Barbara Palumbo, Maria Cristina Marzola, Laura Evangelista, Orazio Schillaci
Radiomics and theranostics with molecular and metabolic probes in prostate cancer: toward a personalized approach. Expert review of molecular diagnostics (2023)
Luca Filippi, Laura Evangelista, Orazio Schillaci
Integrated use of 90 Y-labeled microspheres and immune checkpoint inhibitors in hepatic tumors: current status and future directions. Expert review of gastroenterology & hepatology (2023)
Marco Alfonso Merrone, Andrea Cimini, Maria Ricci, Milena Pizzoferro, Maria Carmen Garganese, Massimiliano Raponi, Orazio Schillaci
Myocardial Functional Imaging in Pediatric Nuclear Cardiology. Journal of cardiovascular development and disease 10 (9) (2023)
Laura Evangelista, Viviana Frantellizzi, Orazio Schillaci, Luca Filippi
Radiolabeled FAPI in pancreatic cancer: can it be an additional value in the management of patients? Expert review of anticancer therapy (2023)
Luca Filippi, Laura Evangelista, Orazio Schillaci
Integrated use of 90 Y-labeled microspheres and immune checkpoint inhibitors in hepatic tumors: current status and future directions. Expert review of gastroenterology & hepatology (2023)
Nicola Fazio, Massimo Falconi, Emanuela Foglia, Mirco Bartolomei, Alfredo Berruti, Mirko D'Onofrio, Diego Ferone, Alessandro Giordano, Franco Grimaldi, Massimo Milione, Francesco Panzuto, Monica Santimaria, Orazio Schillaci, Ettore Seregni, Michele Stasi, Marco Volante, Secondo Lastoria
Optimising Radioligand Therapy for Patients with Gastro-Entero-Pancreatic Neuroendocrine Tumours: Expert Opinion from an Italian Multidisciplinary Group. Advances in therapy (2023)
Laura Evangelista, Viviana Frantellizzi, Orazio Schillaci, Luca Filippi
Radiolabeled FAPI in pancreatic cancer: can it be an additional value in the management of patients? Expert review of anticancer therapy (2023)
Luca Filippi, Oreste Bagni, Orazio Schillaci
Digital PET/CT with 18 F-FACBC in early castration-resistant prostate cancer: our preliminary results. Expert review of medical devices 19 (7) (2022)
Luca Filippi, Orazio Schillaci, Barbara Palumbo
Neuroimaging with PET/CT in chronic traumatic encephalopathy: what nuclear medicine can do to move the field forward. Expert review of molecular diagnostics 22 (2) (2022)
Luca Filippi, Antonia Dimitrakopoulou-Strauss, Laura Evangelista, Orazio Schillaci
Long axial field-of-view PET/CT devices: are we ready for the technological revolution? Expert review of medical devices 19 (10) (2022)
Luca Filippi, Barbara Palumbo, Viviana Frantellizzi, Susanna Nuvoli, Giuseppe De Vincentis, Angela Spanu, Orazio Schillaci
Prostate-specific membrane antigen-directed imaging and radioguided surgery with single-photon emission computed tomography: state of the art and future outlook. Expert review of medical devices (2022)
Joana Gorica, Maria Silvia De Feo, Luca Filippi, Viviana Frantellizzi, Orazio Schillaci, Giuseppe De Vincentis
Gastrin-releasing peptide receptor agonists and antagonists for molecular imaging of breast and prostate cancer: from pre-clinical studies to translational perspectives. Expert review of molecular diagnostics (2022)
Luca Filippi, Orazio Schillaci
Digital PET and detection of recurrent prostate cancer: what have we gained, and what is still missing? Expert review of medical devices 18 (11) (2021)
Luca Filippi, Agostino Chiaravalloti, Orazio Schillaci, Oreste Bagni
The potential of PSMA-targeted alpha therapy in the management of prostate cancer. Expert review of anticancer therapy 20 (10) (2020)
Luca Filippi, Agostino Chiaravalloti, Orazio Schillaci, Roberto Cianni, Oreste Bagni
Theranostic approaches in nuclear medicine: current status and future prospects. Expert review of medical devices 17 (4) (2020)
Orazio Schillaci, Nicoletta Urbano
Digital PET/CT: a new intriguing chance for clinical nuclear medicine and personalized molecular imaging. European journal of nuclear medicine and molecular imaging 46 (6) (2019)
Luca Filippi, Orazio Schillaci, Oreste Bagni
Recent advances in PET probes for hepatocellular carcinoma characterization. Expert review of medical devices 16 (5) (2019)

Orazio Schillaci.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Orazio Schillaci